Indus Herbs Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 15-11-2024
- Paid Up Capital ₹ 4.75 M
as on 15-11-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.98 Cr
as on 15-11-2024
- Revenue -18.26%
(FY 2023)
- Profit -1.70%
(FY 2023)
- Ebitda 10.68%
(FY 2023)
- Net Worth 108.43%
(FY 2023)
- Total Assets -32.01%
(FY 2023)
About Indus Herbs
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.75 M.
The company currently has active open charges totaling ₹1.98 Cr.
Pavitra Hegde and Chandrashekar Raveendra serve as directors at the Company.
- CIN/LLPIN
U51909KA2020PTC137928
- Company No.
137928
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Aug 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Indus Herbs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pavitra Hegde  | Director | 31-Aug-2020 | Current |
| Chandrashekar Raveendra | Director | 31-Aug-2020 | Current |
Financial Performance of Indus Herbs.
Indus Herbs Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18.26% decrease. The company also saw a slight decrease in profitability, with a 1.7% decrease in profit. The company's net worth Soared by an impressive increase of 108.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indus Herbs?
Unlock access to Indus Herbs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Agasthya Naturals Private LimitedActive 4 years 6 monthsPavitra Hegde and Chandrashekar Raveendra are mutual person
- Nityasanjeevini Essentials Private LimitedActive 4 years 6 months
Chandrashekar Raveendra is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 02 Nov 2023 | ₹1.98 Cr | Open |
How Many Employees Work at Indus Herbs?
Indus Herbs has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indus Herbs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indus Herbs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
